Opus Genetics (IRD) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.43% |
| Dec 31, 2025 | -22.42% |
| Sep 30, 2025 | -30.69% |
| Jun 30, 2025 | -28.63% |
| Mar 31, 2025 | -30.61% |
| Dec 31, 2024 | -46.24% |
| Sep 30, 2024 | -21.34% |
| Jun 30, 2024 | -20.56% |
| Mar 31, 2024 | -21.23% |
| Dec 31, 2023 | -27.96% |
| Sep 30, 2023 | -27.54% |
| Jun 30, 2023 | -19.04% |
| Mar 31, 2023 | -12.99% |
| Dec 31, 2022 | -9.73% |
| Sep 30, 2022 | 9.67% |
| Jun 30, 2022 | 8.52% |
| Mar 31, 2022 | -0.93% |
| Dec 31, 2021 | -4.03% |
| Sep 30, 2021 | -0.74% |
| Jun 30, 2021 | -4.55% |
| Mar 31, 2021 | 15.41% |
| Dec 31, 2020 | 6.89% |
| Sep 30, 2020 | 17.74% |
| Jun 30, 2020 | 18.74% |
| Mar 31, 2020 | 17.84% |
| Dec 31, 2019 | 32.64% |
| Sep 30, 2019 | 17.12% |
| Jun 30, 2019 | 15.70% |
| Mar 31, 2019 | 14.82% |
| Dec 31, 2018 | 4.76% |
| Sep 30, 2018 | 3.44% |
| Jun 30, 2018 | -10.68% |
| Mar 31, 2018 | -11.72% |
| Dec 31, 2017 | -14.58% |
| Sep 30, 2017 | -25.41% |
| Jun 30, 2017 | -25.55% |
| Mar 31, 2017 | -12.98% |
| Dec 31, 2016 | -11.46% |
| Sep 30, 2016 | -7.54% |
| Jun 30, 2016 | -1.42% |
| Mar 31, 2016 | -3.59% |
| Dec 31, 2015 | -9.64% |
| Sep 30, 2015 | -6.27% |
| Jun 30, 2015 | -7.84% |